Merck R&D Renaissance To Continue With Three NDA Filings In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
During Dec. 12 investor meeting, Merck Research Labs President Peter Kim says firm will file NDAs for compounds to treat HIV, insomnia and atherosclerosis in 2007.